NICE deadline re: new immunotherapy drug

Please read and help share this blog post: The deadline is Tuesday 26th July for further submissions to NICE regarding the licensing and funding of Nivolumab. This new immunotherapy PD-1 type drug is so important to all kidney cancer patients everywhere. We are still hoping for some positive scan results for Jon in time to […]

Read more